# A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood

> **NCT07211425** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3031185
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT07211425
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-08
- **Primary completion:** 2026-01-21
- **Final completion:** 2026-01-21
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211425, "A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07211425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*